|
1
|
Lai NS, Wu DG, Fang XG, Lin YC, Chen SS,
Li ZB and Xu SS: Serum microRNA-210 as a potential noninvasive
biomarker for the diagnosis and prognosis of glioma. Br J Cancer.
112:1241–1246. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chow KK, Naik S, Kakarla S, Brawley VS,
Shaffer DR, Yi Z, Rainusso N, Wu MF, Liu H, Kew Y, et al: T cells
redirected to EphA2 for the immunotherapy of glioblastoma. Mol
Ther. 21:629–637. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wang K, Kievit FM, Jeon M, Silber JR,
Ellenbogen RG and Zhang M: Nanoparticle-mediated target delivery of
TRAIL as gene therapy for glioblastoma. Adv Healthc Mater.
4:2719–2726. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Delfino KR, Serão NV, Southey BR and
Rodriguez-Zas SL: Therapy-, gender- and race-specific microRNA
markers, target genes and networks related to glioblastoma
recurrence and survival. Cancer Genomics Proteomics. 8:173–183.
2011.PubMed/NCBI
|
|
5
|
Koekkoek JA, Postma TJ, Heimans JJ,
Reijneveld JC and Taphoorn MJ: Antiepileptic drug treatment in the
end-of-life phase of glioma patients: A feasibility study. Support
Care Cancer. 24:1633–1638. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wang J, Su HK, Zhao HF, Chen ZP and To SS:
Progress in the application of molecular biomarkers in gliomas.
Biochem Biophys Res Commun. 465:1–4. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Delgado-López PD and Corrales-García EM:
Survival in glioblastoma: A review on the treatment modalities.
Clin Transl Oncol. 18:1062–1071. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Li C, Jing H, Ma G and Liang P: Allicin
induces apoptosis through activation of both intrinsic and
extrinsic pathways in glioma cells. Mol Med Rep. 17:5976–5981.
2018.PubMed/NCBI
|
|
9
|
Mrugala MM: Advances and challenges in the
treatment of glioblastoma: A clinician's perspective. Discov Med.
83:221–230. 2013.
|
|
10
|
Maruyama R and Suzuki H: Long noncoding
RNA involvement in cancer. BMB Rep. 45:604–611. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Spizzo R, Almeida MI, Colombatti A and
Calin GA: Long non-coding RNAs and cancer: A new frontier of
translational research. Oncogene. 31:4577–4587. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Grzmil M, Morin P Jr, Lino MM, Merlo A,
Frank S, Wang Y, Moncayo G and Hemmings BA: MAP kinase-interacting
kinase 1 regulates SMAD2- dependent TGF-β signaling pathway in
human glioblastoma. Cancer Res. 71:2392–2402. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang S, Wang W, Liu G, Xie S, Li Q, Li Y
and Lin Z: Long non-coding RNA HOTTIP promotes hypoxia-induced
epithelial-mesenchymal transition of malignant glioma by regulating
the miR-101/ZEB1 axis. Biomed Pharmacother. 95:711–720. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zeng J, Du T, Song Y, Gao Y, Li F, Wu R,
Chen Y, Li W, Zhou H, Yang Y and Pei Z: Knockdown of long noncoding
RNA CCAT2 inhibits cellular proliferation, invasion, and EMT in
glioma cells. Oncol Res. 6:913–921. 2017. View Article : Google Scholar
|
|
15
|
Salmena L, Poliseno L, Tay Y, Kats L and
Pandolfi PP: A ceRNA hypothesis: The rosetta stone of a hidden RNA
language? Cell. 146:353–358. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sullivan TB, Robert LC, Teebagy PA, Morgan
SE, Beatty EW, Cicuto BJ, Nowd PK, Rieger-Christ KM and Bryan DJ:
Spatiotemporal microRNA profile in peripheral nerve regeneration:
miR-138 targets vimentin and inhibits schwann cell migration and
proliferation. Neural Regen Res. 13:1253–1262. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tay Y, Kats L, Salmena L, Weiss D, Tan SM,
Ala U, Karreth F, Poliseno L, Provero P, Di Cunto F, et al:
Coding-independent regulation of the tumor suppressor PTEN by
competing endogenous mRNAs. Cell. 2:344–357. 2011. View Article : Google Scholar
|
|
18
|
Lv J, Fan HX, Zhao XP, Lv P, Fan JY, Zhang
Y, Liu M and Tang H: Long non-coding RNA unigene56159 promotes
epithelial-mesenchymal transition by acting as a ceRNA of
miR-140-5p in hepatocellular carcinoma cells. Cancer Lett.
2:166–175. 2016. View Article : Google Scholar
|
|
19
|
Zhang Z, Lei B, Wu H, Zhang X and Zheng N:
Tumor suppressive role of miR-194-5p in glioblastoma multiform. Mol
Med Rep. 6:9317–9322. 2017. View Article : Google Scholar
|
|
20
|
Wang Y, Yang L, Chen T, Liu X, Guo Y, Zhu
Q, Tong X, Yang W, Xu Q, Huang D and Tu K: A novel lncRNA
MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by
targeting miR-194-5p/FOXA1 axis. Mol Cancer. 1:282019. View Article : Google Scholar
|
|
21
|
Dell'Aversana C, Giorgio C, D'Amato L,
Lania G, Matarese F, Saeed S, Di Costanzo A, Belsito Petrizzi V,
Ingenito C, Martens JHA, et al: MiR-194-5p/BCLAF1 deregulation in
AML tumorigenesis. Leukemia. 11:2315–2325. 2017. View Article : Google Scholar
|
|
22
|
Zhang Q, Wei T, Shim K, Wright K, Xu K,
Palka-Hamblin HL, Jurkevich A and Khare S: Atypical role of sprouty
in colorectal cancer: Sprouty repression inhibits
epithelial-mesenchymal transition. Oncogene. 24:3151–3162. 2016.
View Article : Google Scholar
|
|
23
|
Meng Z, Fu X, Chen X, Zeng S, Tian Y, Jove
R, Xu R and Huang W: MiR-194 is a marker of hepatic epithelial
cells and suppresses metastasis of liver cancer cells in mice.
Hepatology. 6:2148–2157. 2010. View Article : Google Scholar
|
|
24
|
Huang Da W, Sherman BT and Lempicki RA:
Systematic and integrative analysis of large gene lists using DAVID
bioinformatics resources. Nat Protoc. 4:44–57. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Robinson MD, Mccarthy DJ and Smyth GK:
edgeR: A bioconductor package for differential expression analysis
of digital gene expression data. Bioinformatics. 1:139–140. 2010.
View Article : Google Scholar
|
|
26
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Benjamini Y and Hochberg Y: Controlling
the false discovery rate - A practical and powerful approach to
multiple testing. J R Stat Soc. 1:289–300. 1995.
|
|
28
|
Egeblad M and Werb Z: New functions for
the matrix metalloproteinases in cancer progression. Nat Rev
Cancer. 3:161–174. 2002. View
Article : Google Scholar
|
|
29
|
Mayer A, Takimoto M, Fritz E, Schellander
G, Kofler K and Ludwig H: The prognostic significance of
proliferating cell nuclear antigen, epidermal growth factor
receptor, and mdr gene expression in colorectal cancer. Cancer.
8:2454–2460. 2015.
|
|
30
|
Gibb EA, Brown CJ and Lam WL: The
functional role of long non-coding RNA in human carcinomas. Mol
Cancer. 10:382011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Qi X, Zhang DH, Wu N, Xiao JH, Wang X and
Ma W: CeRNA in cancer: Possible functions and clinical
implications. J Med Genet. 10:710–718. 2015. View Article : Google Scholar
|
|
32
|
Tang J, Li Y, Sang Y, Yu B, Lv D, Zhang W
and Feng H: LncRNA PVT1 regulates triple-negative breast cancer
through KLF5/beta-catenin signaling. Oncogene. 34:4723–4734. 2018.
View Article : Google Scholar
|
|
33
|
Sun J, Zhang S, Liu Y, Shan B, Zheng D and
Shi J: The lncRNA SNHG5/miR-32 axis regulates gastric cancer cell
proliferation and migration by targeting KLF4. FASEB J. 31:893–903.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Cui Y, Zhang F, Zhu C, Geng L, Tian T and
Liu H: Upregulated lncRNA SNHG1 contributes to progression of
non-small cell lung cancer through inhibition of miR-101-3p and
activation of Wnt/β-catenin signaling pathway. Oncotarget.
8:17785–17794. 2017.PubMed/NCBI
|
|
35
|
Lu W, Zhang H, Niu Y, Wu Y, Sun W, Li H,
Kong J, Ding K, Shen HM, Wu H, et al: Long non-coding RNA linc00673
regulated non-small cell lung cancer proliferation, migration,
invasion and epithelial mesenchymal transition by sponging
miR-150-5p. Mol Cancer. 16:1182017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Cesana M, Cacchiarelli D, Legnini I,
Santini T, Sthandier O, Chinappi M, Tramontano A and Bozzoni I: A
long noncoding RNA controls muscle differentiation by functioning
as a competing endogenous RNA. Cell. 147:358–369. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Karreth FA, Tay Y, Perna D, Ala U, Tan SM,
Rust AG, DeNicola G, Webster KA, Weiss D, Perez-Mancera PA, et al:
In vivo identification of tumor- suppressive PTEN ceRNAs in an
oncogenic BRAF-induced mouse model of melanoma. Cell. 147:382–395.
2011. View Article : Google Scholar : PubMed/NCBI
|
